529 related articles for article (PubMed ID: 24373314)
1. Bacteriophages of Pseudomonas aeruginosa: long-term prospects for use in phage therapy.
Krylov VN
Adv Virus Res; 2014; 88():227-78. PubMed ID: 24373314
[TBL] [Abstract][Full Text] [Related]
2. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C
mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
[TBL] [Abstract][Full Text] [Related]
3. Assessing phage therapy against Pseudomonas aeruginosa using a Galleria mellonella infection model.
Beeton ML; Alves DR; Enright MC; Jenkins AT
Int J Antimicrob Agents; 2015 Aug; 46(2):196-200. PubMed ID: 26100212
[TBL] [Abstract][Full Text] [Related]
4. A genetic approach to the development of new therapeutic phages to fight pseudomonas aeruginosa in wound infections.
Krylov V; Shaburova O; Krylov S; Pleteneva E
Viruses; 2012 Dec; 5(1):15-53. PubMed ID: 23344559
[TBL] [Abstract][Full Text] [Related]
5. Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients.
Sahota JS; Smith CM; Radhakrishnan P; Winstanley C; Goderdzishvili M; Chanishvili N; Kadioglu A; O'Callaghan C; Clokie MR
J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):353-60. PubMed ID: 25714328
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients.
Olszak T; Zarnowiec P; Kaca W; Danis-Wlodarczyk K; Augustyniak D; Drevinek P; de Soyza A; McClean S; Drulis-Kawa Z
Appl Microbiol Biotechnol; 2015 Jul; 99(14):6021-33. PubMed ID: 25758956
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas biofilms, cystic fibrosis, and phage: a silver lining?
Brüssow H
mBio; 2012; 3(2):. PubMed ID: 22493030
[TBL] [Abstract][Full Text] [Related]
8. Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvae.
Hall AR; De Vos D; Friman VP; Pirnay JP; Buckling A
Appl Environ Microbiol; 2012 Aug; 78(16):5646-52. PubMed ID: 22660719
[TBL] [Abstract][Full Text] [Related]
9. Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections.
Pires DP; Vilas Boas D; Sillankorva S; Azeredo J
J Virol; 2015 Aug; 89(15):7449-56. PubMed ID: 25972556
[TBL] [Abstract][Full Text] [Related]
10. Bacteriophages in the experimental treatment of Pseudomonas aeruginosa infections in mice.
Saussereau E; Debarbieux L
Adv Virus Res; 2012; 83():123-41. PubMed ID: 22748810
[TBL] [Abstract][Full Text] [Related]
11. Selection of phages and conditions for the safe phage therapy against Pseudomonas aeruginosa infections.
Krylov V; Shaburova O; Pleteneva E; Krylov S; Kaplan A; Burkaltseva M; Polygach O; Chesnokova E
Virol Sin; 2015 Feb; 30(1):33-44. PubMed ID: 25680443
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.
Saussereau E; Vachier I; Chiron R; Godbert B; Sermet I; Dufour N; Pirnay JP; De Vos D; Carrié F; Molinari N; Debarbieux L
Clin Microbiol Infect; 2014 Dec; 20(12):O983-90. PubMed ID: 24920209
[TBL] [Abstract][Full Text] [Related]
13. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
[TBL] [Abstract][Full Text] [Related]
14. Survey of Pseudomonas aeruginosa and its phages: de novo peptide sequencing as a novel tool to assess the diversity of worldwide collected viruses.
Ceyssens PJ; Noben JP; Ackermann HW; Verhaegen J; De Vos D; Pirnay JP; Merabishvili M; Vaneechoutte M; Chibeu A; Volckaert G; Lavigne R
Environ Microbiol; 2009 May; 11(5):1303-13. PubMed ID: 19207572
[TBL] [Abstract][Full Text] [Related]
15. Characterization of lytic Pseudomonas aeruginosa bacteriophages via biological properties and genomic sequences.
Karumidze N; Thomas JA; Kvatadze N; Goderdzishvili M; Hakala KW; Weintraub ST; Alavidze Z; Hardies SC
Appl Microbiol Biotechnol; 2012 Jun; 94(6):1609-17. PubMed ID: 22562168
[TBL] [Abstract][Full Text] [Related]
16. Improving the Inhibitory Effect of Phages against
Aghaee BL; Khan Mirzaei M; Alikhani MY; Mojtahedi A; Maurice CF
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670028
[TBL] [Abstract][Full Text] [Related]
17. [Bacteriophage phi297--the new species of temperate phages Pseudomonas aeruginosa with a mosaic genome: potential use in phagotherapy].
Burkal'tseva MV; Krylov SV; Kropinskiĭ AM; Pletneva EA; Shaburova OV; Krylov VN
Genetika; 2011 Jul; 47(7):900-4. PubMed ID: 21938953
[TBL] [Abstract][Full Text] [Related]
18. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice.
Vinodkumar CS; Kalsurmath S; Neelagund YF
Indian J Pathol Microbiol; 2008; 51(3):360-6. PubMed ID: 18723958
[TBL] [Abstract][Full Text] [Related]
19. [Pseudolysogeny of Pseudomonas aeruginosa bacteria infected with phiKZ-like bacteriophages].
Pletnev EA; Krylov SV; Shaburova OV; Burkal'tseva MV; Miroshnikov KA; Krylov VN
Genetika; 2010 Jan; 46(1):26-32. PubMed ID: 20198876
[TBL] [Abstract][Full Text] [Related]
20. Use of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 biofilms.
Pires D; Sillankorva S; Faustino A; Azeredo J
Res Microbiol; 2011 Oct; 162(8):798-806. PubMed ID: 21782936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
